Clinical Trials Logo
  1. Home
  2. Memory
  3. NCT00969696

Galantamine Effects on Cognitive Function in Marijuana Users

Memory Clinical Trial

Official title:
Galantamine Effects on Cognitive Function in Marijuana Users

Clinical Trial Summary

To evaluate galantamine's effects on cognitive performance in marijuana users. Galantamine, an acetylcholine esterase inhibitor, is approved for treatment of Alzheimer's disease. Current marijuana users show impaired cognitive functioning, which predicts poor treatment response to behavioral treatments in this population. Whether cognitive impairment in marijuana users will improve with medication treatment has not been evaluated. We hypothesize that galantamine, compared to placebo, will improve cognitive performance in marijuana users.Galantamine, compared to placebo, will improve working memory, verbal learning/memory and response inhibition functions in marijuana users.

Clinical Trial Description

To summarize, marijuana users show impaired cognitive functioning, especially in working memory and verbal learning and memory functions. Impaired cognitive functioning predicts poor treatment response in marijuana users. Whether the cognitive impairments in marijuana users improve with cholinergic enhancers has not been evaluated. In this double-blind, parallel-group study, we are proposing to evaluate galantamine's effects on cognitive performance in marijuana users. Thirty subjects will first have an adaptation session to familiarize them with the study procedures including cognitive assessment. The adaptation session will be followed by a 10-day treatment period, in which subjects will be randomized to galantamine (8 mg/day) or placebo. On Day 4 or 5 and Day 9 or10 of each treatment phase subjects will have test sessions, where a battery of cognitive tests will be administered. The cognitive test that will be administered will include the Hopkins Verbal Learning Test (HVLT) modules from the Cambridge Neuropsychological Test Automated Battery (CANTAB): the Rapid Visual Information Processing (RVIP) and the Stop Signal Test (SST).

Currently this study is in data analysis with 30 completers. (April 2011) ;

Study Design

Allocation: Non-Randomized, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Screening

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT00969696
Study type Interventional
Source Yale University
Contact
Status Completed
Phase Phase 1
Start date August 2009
Completion date July 2011
View Details
See also
  Status Clinical Trial Phase
Completed NCT01007682 - Intrusive Reexperiencing: The Role of Working Memory Capacity and Thought Suppression N/A
Completed NCT04330677 - Dissecting the Role of Estradiol in Mediating Gender-specific Anxiolytic and Prosocial Effects of Oxytocin Phase 1
Active, not recruiting NCT04392908 - Communication Memory of Cancer Diagnosis Within the Pediatric Triangle
Recruiting NCT04694534 - Remediation Program Via a "Serious Game" for the Cognitive Functions of Multiple Sclerosis Patients N/A
Completed NCT01159652 - Hypnotic Medications and Memory: Effect of Drug Exposure During the Night Phase 4
Recruiting NCT04598945 - Acquisition and Retention of Motor Memories in Adults and Typically Developing Children N/A
Terminated NCT04021797 - Autonomic Mechanisms of Sleep-dependent Memory Consolidation N/A
Not yet recruiting NCT04103463 - Interactive Stepping Exercise on Memory N/A
Completed NCT04025255 - The Memory and Cognitive Performance Study N/A
Recruiting NCT06351098 - Longitudinal Investigation of Sleep, Memory, and Brain Development Across the Nap Transition Early Phase 1
Completed NCT06047899 - Influence of Luteolin for Two Weeks on Memory in Healthy Subjects N/A
Recruiting NCT04402294 - Individualized Closed Loop TMS for Working Memory Enhancement N/A
Completed NCT01126229 - Resveratrol for Improved Performance in the Elderly Phase 1
Completed NCT00913640 - Prospective Memory in Parkinson's Disease
Completed NCT03974399 - BDNF Levels After Bacopa N/A
Completed NCT01143194 - A Randomized, Placebo-Controlled, Double-Blind, Crossover Study to Evaluate the Effects of Three Doses of the Dietary Supplement oréVida™ on Alertness, Attention and Concentration in Healthy Men and Women Phase 1
Completed NCT00454454 - Virtual Reality Helmet to Test for Problems With Memory N/A
Completed NCT00584324 - Depth of Anesthesia on Implicit Memory N/A
Completed NCT06074172 - The Effect of Cannabidiol in Learning and Memory of Adults Phase 2
Completed NCT03763409 - Losartan and Emotional Memory N/A